Xenetic Biosciences (XBIO)
(Delayed Data from NSDQ)
$3.90 USD
-0.15 (-3.62%)
Updated May 10, 2024 03:49 PM ET
After-Market: $3.85 -0.05 (-1.17%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth D Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/9/24 |
---|---|
Current Quarter | -0.83 |
EPS Last Quarter | -0.78 |
Last EPS Surprise | 1.27% |
ABR | 3.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -3.43 |
Next Year | -0.82 |
EPS (TTM) | -2.93 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.67M | 0.70M | 2.70M | 1.80M |
# of Estimates | 1 | 1 | 1 | 1 |
High Estimate | 0.67M | 0.70M | 2.70M | 1.80M |
Low Estimate | 0.67M | 0.70M | 2.70M | 1.80M |
Year ago Sales | 0.65M | 0.61M | 2.54M | 2.70M |
Year over Year Growth Est. | 3.08% | 14.75% | 6.30% | -33.33% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.83 | -0.15 | -3.43 | -0.82 |
# of Estimates | 1 | 1 | 1 | 1 |
Most Recent Consensus | -0.83 | -0.15 | -3.43 | -0.82 |
High Estimate | -0.83 | -0.15 | -3.43 | -0.82 |
Low Estimate | -0.83 | -0.15 | -3.43 | -0.82 |
Year ago EPS | -0.69 | -0.69 | -2.71 | -3.43 |
Year over Year Growth Est. | -20.29% | 78.26% | -26.57% | 76.09% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 1 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.83 | -0.15 | -3.43 | -0.82 |
7 Days Ago | -0.83 | -0.15 | -3.43 | -0.82 |
30 Days Ago | -0.83 | -0.15 | -3.43 | -0.82 |
60 Days Ago | NA | NA | -0.64 | -0.93 |
90 Days Ago | NA | NA | -0.64 | -0.93 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.83 | -0.15 | -3.43 | -0.82 |
Zacks Consensus Estimate | -0.83 | -0.15 | -3.43 | -0.82 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.78 | -0.77 | -0.69 | -0.69 | NA |
Estimate | -0.79 | -0.87 | -1.12 | -1.13 | NA |
Difference | 0.01 | 0.10 | 0.43 | 0.44 | 0.25 |
Surprise | 1.27% | 11.49% | 38.39% | 38.94% | 22.52% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more